Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KYNB holding history

Kyntra Bio, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYNB overviewAll 13F holders of KYNBFull Q2 2026 holdings

Shares (Q2 2026)
7,857
Value
$59.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KYNB by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,857$59.3K<0.1%−19,734−71.5%ReducedHolders
Q1 202627,591$187.1K<0.1%+18,159+192.5%AddedHolders
Q4 20259,432$82.8K<0.1%+765+8.8%AddedHolders
Q3 20258,667$106.2K<0.1%−1,620−15.7%ReducedHolders
Q2 202510,287$54.5K<0.1%+465+4.7%AddedConverted for a 1-for-25 splitHolders
Q1 2025245,555$76.1K<0.1%+48,920+24.9%AddedHolders
Q4 2024196,635$104.0K<0.1%+171,972+697.3%AddedHolders
Q3 202424,663$9.84K<0.1%−44,696−64.4%ReducedHolders
Q2 202469,359$61.9K<0.1%−31,711−31.4%ReducedHolders
Q1 2024101,070$237.5K<0.1%+19,991+24.7%AddedHolders
Q4 202381,079$71.8K<0.1%+80,385+11,582.9%AddedHolders
Q3 2023694$599<0.1%−101,742−99.3%ReducedHolders
Q2 2023102,436$276.6K<0.1%+77,869+317.0%AddedHolders
Q1 202324,567$458.4K<0.1%−170,888−87.4%ReducedHolders
Q4 2022195,455$3.13M<0.1%+153,891+370.3%AddedHolders
Q3 202241,564$541.0K<0.1%−43,659−51.2%ReducedHolders
Q2 202285,223$900.0K<0.1%−182,849−68.2%ReducedHolders
Q1 2022268,072$3.22M<0.1%+24,405+10.0%AddedHolders
Q4 2021243,667$3.44M<0.1%−62,215−20.3%ReducedHolders
Q3 2021305,882$3.13M<0.1%+269,830+748.4%AddedHolders
Q2 202136,052$960.0K<0.1%−54,862−60.3%ReducedHolders
Q1 202190,914$3.16M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.